1,828
Views
1
CrossRef citations to date
0
Altmetric
Articles

The efficiency of prostate-specific antigen density measurement using three different methods on the prediction of biochemical recurrence

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 15-23 | Received 02 Nov 2020, Accepted 27 Apr 2021, Published online: 18 May 2021

References

  • Salman J, Schoots I, Carlsson S, et al. Prostate specific antigen as a tumor marker in prostate cancer: biochemical and clinical aspects. Adv Exp Med Biol. 2015;867:93–114.
  • Loeb S, Dani H. Whom to biopsy: pre-diagnostic risk stratification with biomarkers, nomograms and risk calculators. Urol Clin North Am. 2017;44(4):517–524.
  • Erdogan A, Polat S, Keskin E, et al. Is prostate volume better than PSA density and free/total PSA ratio in predicting prostate cancer in patients with PSA 2.5–10 ng/mL and 10.1–30 ng/mL? Aging Male. 2020;23(1):59–65.
  • Nordström T, Akre O, Aly M, et al. Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer. Prostate Cancer Prostatic Dis. 2018;21(1):57–63.
  • Brassell SA, Kao T-C, Sun L, et al. Prostate-specific antigen versus prostate-specific antigen density as predictor of tumor volume, margin status, pathologic stage, and biochemical recurrence of prostate cancer. Urology. 2005;66(6):1229–1233.
  • Freedland SJ, Kane CJ, Presti JJ, et al. Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data base. J Urol. 2003;169(3):969–973.
  • Kundu SD, Roehl KA, Yu X, et al. Prostate specific antigen density correlates with features of prostate cancer aggressiveness. J Urol. 2007;177(2):505–509.
  • Bezinque A, Moriarity A, Farrell C, et al. Determination of prostate volume: a comparison of contemporary methods. Acad Radiol. 2018;25(12):1582–1587.
  • Mazaheri Y, Goldman DA, Di Paolo PL, et al. Comparison of prostate volume measured by endorectal coil MRI to prostate specimen volume and mass after radical prostatectomy. Acad Radiol. 2015;22(5):556–562.
  • Roobol MJ, van Vugt HA, Loeb S, et al. Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators. Eur Urol. 2012;61(3):577–583.
  • Paterson NR, Lavallée LT, Nguyen LN, et al. Prostate volume estimations using magnetic resonance imaging and transrectal ultrasound compared to radical prostatectomy specimens. Can Urol Assoc J. 2016;10(7–8):264–268.
  • Toth R, Bloch BN, Genega EM, et al. Accurate prostate volume estimation using multifeature active shape models on T2-weighted MRI. Acad Radiol. 2011;18(6):745–754.
  • Rasch C, Barillot I, Remeijer P, et al. Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys. 1999;43(1):57–66.
  • Jeong CW, Park HK, Hong SK, et al. Comparison of prostate volume measured by transrectal ultrasonography and MRI with the actual prostate volume measured after radical prostatectomy. Urol Int. 2008;81(2):179–185.
  • Varkarakis I, Zarkadoulias A, Bourdoumis A, et al. Measurement of PSA density by 3 imaging modalities and its correlation with the PSA density of radical prostatectomy specimen. Urol Oncol. 2013;31(7):1038–1042.
  • Radwan MH, Yan Y, Luly JR, et al. Prostate-specific antigen density predicts adverse pathology and increased risk of biochemical failure. Urology. 2007;69(6):1121–1127.
  • Cornford P, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer. Eur Urol. 2017;71(4):630–642.
  • Van den Broeck T, van den Bergh RC, Arfi N, et al. Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review. Eur Urol. 2019;75(6):967–987.
  • Bishara S, Vasdev N, Lane T, et al. Robotic prostatectomy has a superior outcome in larger prostates and PSA density is a strong predictor of biochemical recurrence. Prostate Cancer. 2014;2014:1–6.
  • Ün S, Türk H, Koca O, et al. Factors determining biochemical recurrence in low-risk prostate cancer patients who underwent radical prostatectomy. Turk J Urol. 2015;41(2):61–66.
  • Koie T, Mitsuzuka K, Yoneyama T, et al. Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy. Int J Clin Oncol. 2015;20(1):176–181.
  • Magheli A, Rais-Bahrami S, Trock BJ, et al. Prostate specific antigen versus prostate specific antigen density as a prognosticator of pathological characteristics and biochemical recurrence following radical prostatectomy. J Urol. 2008;179(5):1780–1784.
  • Grogan J, Gupta R, Mahon KL, et al. Predictive value of the 2014 International Society of Urological Pathology grading system for prostate cancer in patients undergoing radical prostatectomy with long‐term follow‐up. BJU Int. 2017;120(5):651–658.
  • Abdel Raheem A, Chang KD, Alenzi MJ, et al. Predictors of biochemical recurrence after Retzius‐sparing robot‐assisted radical prostatectomy: analysis of 359 cases with a median follow‐up period of 26 months. Int J Urol. 2018;25(12):1006–1014.
  • Lee JS, Chung BH. Transrectal ultrasound versus magnetic resonance imaging in the estimation of prostate volume as compared with radical prostatectomy specimens. Urol Int. 2007;78(4):323–327.
  • Kilic M, Özdemir AT, Altinova S, et al. What is the best radiological method to predict the actual weight of the prostate? Turk J Med Sci. 2014;44(1):31–35.